Access to high-cost drugs: Decision makers' perspectives

DSpace/Manakin Repository

Search OPUS


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author Gallego, G
dc.contributor.author Melocco, T
dc.contributor.author Taylor, SJ
dc.contributor.author Brien, JE
dc.date.accessioned 2010-05-28T09:50:04Z
dc.date.issued 2005-01
dc.identifier.citation Journal of Pharmacy Practice and Research, 2005, 35 (1), pp. 18 - 20
dc.identifier.issn 1445-937X
dc.identifier.other C1UNSUBMIT en_US
dc.identifier.uri http://hdl.handle.net/10453/9500
dc.description.abstract To explore the attitudes, perceptions and concerns among decision makers about equity of access to high-cost drugs in public hospitals. Method: 25 in-depth, semi-structured interviews were conducted with senior hospital administrators, directors of pharmacy and senior medical doctors. Topics included the decision-making process and associated problems, and solutions to issues of access to high-cost drugs. Interviews were audiotaped, transcribed verbatim and thematically analysed. Results: Healthcare funding models were perceived as obstacles to equity of access to high-cost drugs. Participants were concerned that there were inequities in decisions for individual patients according to public or private sector status. Tertiary public hospitals were seen to be at the 'cutting edge' and therefore were required to fund new and expensive drugs. This meant prioritising between patient groups and individuals. Participants had difficulty in identifying solutions. They suggested that ethical principles should be considered in addition to safety, efficacy and cost. Most wanted a transparent, accountable, evidence-based decision- making process. Conclusion: Decision makers were concerned about equity of access to high-cost drugs in public hospitals. They were also concerned about processes for decision making and the outcomes of these decisions.
dc.publisher Society of Hospital Pharmacists of Australia
dc.rights Copyright Journal of Pharmacy Practice and Research and the Society of Hospital Pharmacists of Australia. en_US
dc.title Access to high-cost drugs: Decision makers' perspectives
dc.type Journal Article
dc.parent Journal of Pharmacy Practice and Research
dc.journal.volume 1
dc.journal.volume 35
dc.journal.number 1 en_US
dc.publocation Australia en_US
dc.identifier.startpage 18 en_US
dc.identifier.endpage 20 en_US
dc.cauo.name BUS.Centre for Health Economics Research and Evaluation en_US
dc.conference Verified OK en_US
dc.for 1115 Pharmacology and Pharmaceutical Sciences
dc.personcode 102201
dc.percentage 100 en_US
dc.classification.name Pharmacology and Pharmaceutical Sciences en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity en_US
dc.description.keywords Attitude of Health Personnel; Decision Making, Organizational; Drug Costs; Hospitals, Public; Pharmaceutical Preparations, economics; Pharmaceutical Preparations, supply and distribution en_US
dc.description.keywords Attitude of Health Personnel
dc.description.keywords Decision Making, Organizational
dc.description.keywords Drug Costs
dc.description.keywords Hospitals, Public
dc.description.keywords Pharmaceutical Preparations, economics
dc.description.keywords Pharmaceutical Preparations, supply and distribution
pubs.embargo.period Not known
pubs.organisational-group /University of Technology Sydney
pubs.organisational-group /University of Technology Sydney/Faculty of Business
utslib.copyright.status Open Access
utslib.copyright.date 2015-04-15 12:23:47.074767+10
utslib.collection.history General (ID: 2)


Files in this item

This item appears in the following Collection(s)

Show simple item record